Stella Maris Garay
YOU?
Author Swipe
View article: Maillard reaction and protein crosslinking in relation to protein digestibility and gut microbiota in juvenile Nile tilapia (Oreochromis niloticus) raised at different water temperatures
Maillard reaction and protein crosslinking in relation to protein digestibility and gut microbiota in juvenile Nile tilapia (Oreochromis niloticus) raised at different water temperatures Open
View article: Tocilizumab may slow radiographic progression in patients with systemic or polyarticular-course juvenile idiopathic arthritis: post hoc radiographic analysis from two randomized controlled trials
Tocilizumab may slow radiographic progression in patients with systemic or polyarticular-course juvenile idiopathic arthritis: post hoc radiographic analysis from two randomized controlled trials Open
View article: THU0666 SERIOUS/AT LEAST MODERATE INFECTIONS IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS ON SYNTHETIC AND BIOLOGIC DRUGS FROM THE PHARMACHILD REGISTRY
THU0666 SERIOUS/AT LEAST MODERATE INFECTIONS IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS ON SYNTHETIC AND BIOLOGIC DRUGS FROM THE PHARMACHILD REGISTRY Open
View article: Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study
Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study Open
View article: The Argentinian Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
The Argentinian Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) Open
The Juvenile Arthritis Multidimensional Assessment Report (JAMAR) is a new parent/patient reported outcome measure that enables a thorough assessment of the disease status in children with juvenile idiopathic arthritis (JIA). We report the…
View article: The Ecuadorian Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
The Ecuadorian Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) Open
View article: Phenotypic Variability and Disparities in Treatment and Outcomes of Childhood Arthritis Throughout the World: Results from the EPOCA Study
Phenotypic Variability and Disparities in Treatment and Outcomes of Childhood Arthritis Throughout the World: Results from the EPOCA Study Open
View article: Paediatric and adolescent oral abstracts
Paediatric and adolescent oral abstracts Open
Background: Two-year results from the three-part, 5-year, phase III TENDER study showed tocilizumab (TCZ), an IL-6 receptor inhibitor, was effective in the treatment of patients with severe, persistent systemic JIA (sJIA).We report long-te…
View article: O43 5-Year Data from Tender, a Phase III Clinical Trial: Safety and Efficacy of Tocilizumab in Patients with Systemic Juvenile Idiopathic Arthritis
O43 5-Year Data from Tender, a Phase III Clinical Trial: Safety and Efficacy of Tocilizumab in Patients with Systemic Juvenile Idiopathic Arthritis Open